Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „discontinuation“
Suchtreffer
Begriffe & Kennungen
Bavencio · 4.8 · Immune-mediated pneumonitis did not lead to discontinuation of avelumab in any patient. All 3 patients with im
Eintrag öffnenBimzelx · 4.8 · More than 80% of the cases were transient and did not require treatment discontinuation. No serious infections
Eintrag öffnenBortezomib Accord · 4.8 · Table 10: Incidence of peripheral neuropathy in study LYM-3002 by toxicity and treatment discontinuation due t
Eintrag öffnenBortezomib Accord · 4.8 · Table 10: Incidence of peripheral neuropathy in study LYM-3002 by toxicity and treatment discontinuation due t
Eintrag öffnenBortezomib Fresenius Kabi · 4.8 · 22 Table 10: Incidence of peripheral neuropathy in study LYM-3002 by toxicity and treatment discontinuation du
Eintrag öffnenBortezomib Fresenius Kabi · 4.8 · Table 10: Incidence of peripheral neuropathy in study LYM-3002 by toxicity and treatment discontinuation due t
Eintrag öffnenBortezomib Sun · 4.8 · Table 10: Incidence of peripheral neuropathy in study LYM-3002 by toxicity and treatment discontinuation due t
Eintrag öffnenBrilique · 4.8 · In PLATO, patients on ticagrelor had a higher incidence of discontinuation due to adverse events than clopidog
Eintrag öffnenBrilique · 4.8 · In PLATO, patients on ticagrelor had a higher incidence of discontinuation due to adverse events than clopidog
Eintrag öffnenBrilique · 4.8 · In PLATO, patients on ticagrelor had a higher incidence of discontinuation due to adverse events than clopidog
Eintrag öffnenBrintellix · 4.8 · Symptoms upon discontinuation of vortioxetine treatment In the clinical studies, discontinuation symptoms were
Eintrag öffnenBrintellix · 4.8 · Symptoms upon discontinuation of vortioxetine treatment In the clinical studies, discontinuation symptoms were
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · 9 patients randomized to placebo. The adverse reactions most frequently resulting in discontinuation of brivar
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · The discontinuation rate due to adverse reactions was 3.5 %, 3.4 % and 4.0 % for patients randomized to brivar
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · The discontinuation rate due to adverse reactions was 3.5 %, 3.4 % and 4.0 % for patients randomized to brivar
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.8 · The discontinuation rate due to adverse reactions was 3.5 %, 3.4 % and 4.0 % for patients randomized to brivar
Eintrag öffnenCabazitaxel Accord · 4.8 · Discontinuation of treatment due to adverse reactions occurred with similar frequencies across the 3 studies (
Eintrag öffnenCalquence · 4.8 · 56 Of the 284 patients treated with Calquence in combination with venetoclax and obinutuzumab, discontinuation
Eintrag öffnenCalquence · 4.8 · Discontinuation and dose reduction due to adverse reactions
Eintrag öffnenCalquence · 4.8 · Discontinuation and dose reduction due to adverse reactions
Eintrag öffnen